SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-031065
Filing Date
2023-11-09
Accepted
2023-11-09 07:00:13
Documents
17
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20231030d_8k.htm   iXBRL 8-K 25291
2 EXHIBIT 99.1 ex_588374.htm EX-99.1 20838
7 ex_556953img002.jpg GRAPHIC 766
8 monoparlogordg.jpg GRAPHIC 7912
9 twitter.jpg GRAPHIC 795
  Complete submission text file 0001437749-23-031065.txt   205091

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20231109.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20231109_def.xml EX-101.DEF 12188
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20231109_lab.xml EX-101.LAB 16397
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20231109_pre.xml EX-101.PRE 12458
11 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20231030d_8k_htm.xml XML 2757
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 231389970
SIC: 2834 Pharmaceutical Preparations